BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 17149381)

  • 1. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
    Sugano K; Kakizoe T
    Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic aspects of bladder cancer.
    Kim WJ; Quan C
    J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer: translating molecular genetic insights into clinical practice.
    Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
    Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular serological diagnosis in transitional cell bladder cancer.
    von Knobloch R; Brandt H; Hofmann R
    Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case reports on 2 young sisters with superficial bladder neoplasm].
    Tucci G; Pacella A
    G Chir; 1988 Jan; 9(1):36-9. PubMed ID: 3153958
    [No Abstract]   [Full Text] [Related]  

  • 8. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.
    George B; Datar RH; Wu L; Cai J; Patten N; Beil SJ; Groshen S; Stein J; Skinner D; Jones PA; Cote RJ
    J Clin Oncol; 2007 Dec; 25(34):5352-8. PubMed ID: 18048815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers for diagnosis, staging, and prognosis of bladder cancer.
    Williams SG; Buscarini M; Stein JP
    Oncology (Williston Park); 2001 Nov; 15(11):1461-70, 1473-4, 1476; discussion 1476-84. PubMed ID: 11758874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.
    Ahmed HU; Arya M; Patel HR
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1011-22. PubMed ID: 16336092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is protein p53 an independent prognostic factor in bladder carcinoma?].
    Keilholz L
    Strahlenther Onkol; 1995 Sep; 171(9):543-4. PubMed ID: 7570304
    [No Abstract]   [Full Text] [Related]  

  • 12. Bladder cancer: modeling and translation.
    Rosenberg JE; Hahn WC
    Genes Dev; 2009 Mar; 23(6):655-9. PubMed ID: 19299556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1996 May; 8(3):259-63. PubMed ID: 8794154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic markers as promising prognosticators for bladder cancer.
    Kim YK; Kim WJ
    Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and staging of bladder cancer.
    Cummings KB; Barone JG; Ward WS
    Urol Clin North Am; 1992 Aug; 19(3):455-65. PubMed ID: 1636230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial bladder cancer: part 1. Update on etiology, classification and natural history.
    Josephson DY; Pasin E; Stein JP
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1723-34. PubMed ID: 17181486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in bladder cancer diagnostics.
    Sanchez-Carbayo M
    Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of patients with bladder cancer: clinical versus pathologic staging.
    Cummings KB
    Prog Clin Biol Res; 1984; 162A():33-53. PubMed ID: 6483916
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular markers for detection, surveillance and prognostication of bladder cancer.
    Vrooman OP; Witjes JA
    Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in the tertiary prevention of superficial transitional carcinoma of the bladder].
    Comeri G; Belvisi P; Cappoli S; Conti G; Duvia R; Gianneo E; Radice GP
    Arch Ital Urol Nefrol Androl; 1988 Jun; 60(2):147-68. PubMed ID: 2975849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.